Sigachi Industries shares make bumper stock market debut; list at Rs 575, rally 253% from IPO price

By: |
November 15, 2021 11:28 AM

Sigachi Industries shares made a bumper listing on the stock exchanges today. Shares of Sigachi Industries soared 253 per cent to Rs 575 apiece on BSE

Sigachi IndustriesThe Rs 125.43-crore public issue Sigachi Industries had received overwhelming response from investors. Image: Reuters

Sigachi Industries shares made a bumper listing on the stock exchanges today. Shares of Sigachi Industries soared 253 per cent to Rs 575 apiece on BSE, against the issue price of Rs 163 per share. After a few minutes into trade, the shares rose to a new high of Rs 603.75 apiece, a rally of 270 per cent from IPO price. Analysts say that on the back of robust fundamentals and attractive valuations, Sigachi Industries made a stellar debut. The company is the leading manufacturer of MCC (cellulose-based excipient) in India with diversified industry verticals. The IPO was valued at 16x FY21 with no listed peers. The Rs 125.43-crore public issue had received an overwhelming response from investors and was subscribed 101.91 times. Before heading into the IPO, Sigachi Industries raised over Rs 37.62 crore from two anchor investors.

“Even though valuation-wise, Sigachi is attractively valued not only as compared to its peers but also as compared to recently listed companies, our advice will always be to book partial profits on listing gains,” AR Ramachandran, Co-founder & Trainer, Tips2Trades, told Financial Express Online. Ramachandran added that the overall market outlook remains weak due to very high inflationary pressures and having money at hand to buy at lower levels would be a better alternative in the current market situation.

The funds raised through IPO will be utilised to expand production at their Dahej and Jhagadia units in Gujarat. While Rs 2,815.82 lakh will be used in Dahej, Rs 2,924.13 lakh will be used in Jhajharia for the expansion. The company has also planned to use it for general corporate purposes. “One may book profits as the gains are more than 100%. Expect a further increase in price in the coming weeks if earnings are positive,” Manoj Dalmia, Founder and Director, Proficient Equities, said.

MCC is widely used as an excipient for finished dosages in the pharmaceutical industry and has varied applications in food, nutraceuticals, and the cosmetic industries. Currently, the company manufactures 59 different grades of microcrystalline cellulose at its manufacturing units, situated at Hyderabad and Gujarat with an aggregate installed capacity of 11,880 MTPY. “Existing shareholders are advised to hold the stock with a stop loss of Rs 480 while the new investors are advised to wait till the stock prices cool off,” Parth Nyati, Founder – Tradingo, said.

(The stock recommendations in this story are by the respective research analysts and brokerage firms. Financial Express Online does not bear any responsibility for their investment advice. Capital markets investments are subject to rules and regulations. Please consult your investment advisor before investing.)

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Decline in prices of Bitcoin, others hit crypto fund inflows, leads to $40m outflows: Report
2Sensex rallies 886 points as bulls return to Dalal Street, Nifty may breach 17,300 soon
3Star Health IPO share allotment: Check status via BSE, KFintech, grey market premium; listing on Dec 10